HighTower Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
HighTower Advisors's EXEL Position: Q2 2026 in Review
HighTower Advisors increased its Exelixis (EXEL) stake by 86% in Q2 2026, buying an estimated $6.54M and bringing the position to 291,162 shares worth $15.8M. The position accounts for 0.02% of the portfolio, ranked #736.
HighTower Advisors first reported a position in EXEL in Q2 2013 and has held it in 53 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- HighTower Advisors held 291,162 shares of Exelixis worth $15.8M as of Q2 2026.
- HighTower Advisors bought 134,397 Exelixis shares in Q2 2026, an estimated $6.54M.
- Exelixis made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #736 holding.
- HighTower Advisors first reported a position in Exelixis in Q2 2013 and has held it in 53 quarters since.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.